Another study on tumoral immune infiltrates, PD-L1 expression, and the role of CD8/TIA-1 lymphocytes in patients with localized osteosarcoma examined how MDSCs and ICIs influence tumor progression and how combining these therapies can increase treatment efficacy [133]. Here, CD274 is linked to osteosarcoma.